Amylin, a pancreatic peptide hormone, is involved in the regulation of blood glucose as well as appetite; therefore, long-acting amylin analogs have gained increasing interest as monotherapy, and in ...

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Low-dose naltrexone does not provide real clinical benefit for patients with fibromyalgia compared to placebo, according to a clinical trial.

Emerging research says the steroids aren’t a major driver of gestational diabetes, but impacts vary depending on the patient.